Cargando…

Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator

There’s no evidence demonstrating the association between noncoding RNAs levels before IV recombinant tissue plasminogen activator (rtPA) administration and the outcomes of acute ischemic stroke (AIS). 145 AIS patients received rtPA treatment were recruited at the stroke center from 2018 to 2019, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ziping, Li, Lingzhi, Tao, Zhen, Wang, Rongliang, Zhao, Haiping, Zheng, Yangmin, Yang, Zhenhong, Zhong, Liyuan, Fan, Junfen, Luo, Yumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582270/ https://www.ncbi.nlm.nih.gov/pubmed/36278201 http://dx.doi.org/10.3389/fphar.2022.1003806

Ejemplares similares

Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke
por: Zhao, Fangfang, et al.
Publicado: (2022)

Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study
por: Li, Lingzhi, et al.
Publicado: (2023)

Circulating Inflammatory Biomarkers Level before Thrombolysis for Acute Ischemic Stroke Predicts Symptomatic Intracerebral Hemorrhage
por: Li, Lingzhi, et al.
Publicado: (2023)

The Incremental Prognostic Value of Hepatocyte Growth Factor in First-Ever Acute Ischemic Stroke: An Early Link Between Growth Factor and Interleukins
por: Li, Fangfang, et al.
Publicado: (2021)

Pathophysiological Significance of Neutrophilic Transfer RNA-Derived Small RNAs in Asymptomatic Moyamoya Disease
por: Li, Lingzhi, et al.
Publicado: (2021)

MicroRNA-193a-5p Rescues Ischemic Cerebral Injury by Restoring N2-Like Neutrophil Subsets
por: Han, Ziping, et al.
Publicado: (2022)

Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke
por: Chen, Jian, et al.
Publicado: (2021)

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021)

Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke
por: Zhao, Haiping, et al.
Publicado: (2020)

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke
por: Huang, Yuyou, et al.
Publicado: (2023)

Lomitapide ameliorates middle cerebral artery occlusion‐induced cerebral ischemia/reperfusion injury by promoting neuronal autophagy and inhibiting microglial migration
por: Zheng, Yangmin, et al.
Publicado: (2022)

MicroRNA-181c Exacerbates Brain Injury in Acute Ischemic Stroke
por: Ma, Qingfeng, et al.
Publicado: (2016)

Upregulation of MicroRNA-128 in the Peripheral Blood of Acute Ischemic Stroke Patients is Correlated with Stroke Severity Partially through Inhibition of Neuronal Cell Cycle Reentry
por: Liu, Ping, et al.
Publicado: (2019)

MiR-29a Knockout Aggravates Neurological Damage by Pre-polarizing M1 Microglia in Experimental Rat Models of Acute Stroke
por: Zhao, Fangfang, et al.
Publicado: (2021)

Corrigendum: MiR-29a Knockout Aggravates Neurological Damage by Pre-polarizing M1 Microglia in Experimental Rat Models of Acute Stroke
por: Zhao, Fangfang, et al.
Publicado: (2021)

Is the β Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?
por: Yang, Zhenhong, et al.
Publicado: (2023)

Epigenetic Regulation of Oxidative Stress in Ischemic Stroke
por: Zhao, Haiping, et al.
Publicado: (2016)

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
por: Wang, Rongliang, et al.
Publicado: (2016)

Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction
por: Huang, Yuyou, et al.
Publicado: (2021)

Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke
por: Wang, Jue, et al.
Publicado: (2020)

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

Diagnostic and Immunosuppressive Potential of Elevated Mir-424 Levels in Circulating Immune Cells of Ischemic Stroke Patients
por: Li, Guangwen, et al.
Publicado: (2018)

Noncoding RNAs in the Glycolysis of Ovarian Cancer
por: Zhang, Chunmei, et al.
Publicado: (2022)

L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization
por: Li, Fangfang, et al.
Publicado: (2018)

Neuroprotective effects of long noncoding RNAs involved in ischemic postconditioning after ischemic stroke
por: Ma, Wei, et al.
Publicado: (2021)

The Identification and Verification of Key Long Noncoding RNAs in Ischemic Stroke
por: Xu, Houxi, et al.
Publicado: (2020)

Tanhuo Formula Inhibits Astrocyte Activation and Apoptosis in Acute Ischemic Stroke
por: Nie, Yuting, et al.
Publicado: (2022)

Effects of Erythropoietin on Gliogenesis during Cerebral Ischemic/Reperfusion Recovery in Adult Mice
por: Wang, Rongliang, et al.
Publicado: (2017)

MicroRNA-99a-5p in circulating immune cells as a potential biomarker for the early diagnosis of ischemic stroke
por: Zhao, Haiping, et al.
Publicado: (2017)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment
por: Liu, Yonge, et al.
Publicado: (2020)

Functioning of Long Noncoding RNAs Expressed in Macrophage in the Development of Atherosclerosis
por: Ma, Xirui, et al.
Publicado: (2020)

Noncoding RNAs as a novel approach to target retinopathy of prematurity
por: Kim, Hyunjong, et al.
Publicado: (2022)

Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications
por: Zhu, Xueyi, et al.
Publicado: (2020)

Corrigendum: Functioning of Long Noncoding RNAs Expressed in Macrophage in the Development of Atherosclerosis
por: Ma, Xirui, et al.
Publicado: (2021)

Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
por: Jung, Kee-Taig, et al.
Publicado: (2010)

Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
por: Tseng, Yi-Ju, et al.
Publicado: (2020)

TOPK Promotes Microglia/Macrophage Polarization towards M2 Phenotype via Inhibition of HDAC1 and HDAC2 Activity after Transient Cerebral Ischemia
por: Han, Ziping, et al.
Publicado: (2018)

The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
por: Ghionescu, Alina-Veronica, et al.
Publicado: (2023)

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o1lqb746tgnv6u55q6et6rdk5r